Setsuo Funasaka

426 total citations
19 papers, 297 citations indexed

About

Setsuo Funasaka is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Setsuo Funasaka has authored 19 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Surgery. Recurrent topics in Setsuo Funasaka's work include Chemical Synthesis and Analysis (6 papers), Chemical Synthesis and Reactions (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Setsuo Funasaka is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Chemical Synthesis and Reactions (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Setsuo Funasaka collaborates with scholars based in Japan, China and United States. Setsuo Funasaka's co-authors include Teruaki Mukaiyama, Hiroyuki Chiba, Takayuki Nakagawa, Hiroshi Obaishi, Tomohiro Matsushima, Osamu Tohyama, Keiko Takahashi, Makoto Asada, Atsumi Yamaguchi and Kenichi Saito and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Setsuo Funasaka

18 papers receiving 287 citations

Peers

Countries citing papers authored by Setsuo Funasaka

Since Specialization

Citations

This map shows the geographic impact of Setsuo Funasaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuo Funasaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuo Funasaka more than expected).

Fields of papers citing papers by Setsuo Funasaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuo Funasaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuo Funasaka. The network helps show where Setsuo Funasaka may publish in the future.

Co-authorship network of co-authors of Setsuo Funasaka

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuo Funasaka. A scholar is included among the top collaborators of Setsuo Funasaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuo Funasaka. Setsuo Funasaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma 2025 ·Hepatology Research ·(unknown), Chigusa Morizane, Hiroyuki Isayama, (unknown), Masato Endo, Noritoshi Kobayashi, Yasushi Kojima, Shoji Kubo, Saburo Matsubara, Takeshi Shiraishi, Takashi Ohta, Tadashi Uwagawa, (unknown), (unknown), Setsuo Funasaka, Hiroki Ikezawa, Takuji Okusaka	1
2	Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 study 2025 ·Japanese Journal of Clinical Oncology ·Lin Shen, Huaxin Duan, Takamichi Kuwahara, (unknown), Xuelei Ma, Sheng Yan, (unknown), Masafumi Ikeda, Tongjian Cui, Takashi Sasaki, Zhiqiang Meng, Yousuke Nakai, Makoto Ueno, Yoshito Komatsu, Hiroaki Nagano, Chigusa Morizane, Setsuo Funasaka, Hiroki Ikezawa, (unknown), Junji Furuse	1
3	Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor 2024 ·The Journal of Clinical Pharmacology ·(unknown), Tomoko Hasunuma, (unknown), (unknown), (unknown), Setsuo Funasaka, (unknown), Kenya Nakai, Sanae Yasuda	1
4	Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA). 2024 ·Journal of Clinical Oncology ·Junji Furuse, Bo Jiang, Takamichi Kuwahara, Taroh Satoh, Xuelei Ma, Sheng Yan, Haitao Zhao, Masafumi Ikeda, Tongjian Cui, Takashi Sasaki, Zhiqiang Meng, Yousuke Nakai, Makoto Ueno, Yoshito Komatsu, Hiroaki Nagano, Chigusa Morizane, Setsuo Funasaka, Hiroki Ikezawa, (unknown), Lin Shen	9
5	128P Clinical update with plasma and tumour-based genomic analyses in expansion part of phase I study of selective FGFR inhibitor E7090 2020 ·Annals of Oncology ·Chigusa Morizane, Makoto Ueno, (unknown), Masahiro Tajika, Masafumi Ikeda, Kensei Yamaguchi, Hiroki Hara, Hiroshi Yabusaki, Atsushi Miyamoto, Satoru Iwasa, Manabu Muto, Tsutomu Takashima, Keiko Minashi, Yoshito Komatsu, Tomohiro Nishina, Takako Eguchi Nakajima, (unknown), Setsuo Funasaka, Masakazu Yashiro, Junji Furuse	2
6	Expansion part of phase I study of E7090 in patients with cholangiocarcinoma harboring FGFR2 gene fusion and with gastric cancer harboring FGFR2 gene amplification or FGFR2 protein high expression. 2020 ·Journal of Clinical Oncology ·Chigusa Morizane, Makoto Ueno, Tatsuya Ioka, Masahiro Tajika, Masafumi Ikeda, Kensei Yamaguchi, Hiroki Hara, Hiroshi Yabusaki, Atsushi Miyamoto, Satoru Iwasa, Manabu Muto, Tsutomu Takashima, Keiko Minashi, Yoshito Komatsu, Tomohiro Nishina, Takako Eguchi Nakajima, (unknown), Setsuo Funasaka, Masakazu Yashiro, Junji Furuse	5
7	Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 2019 ·European Journal of Cancer ·Peng Yuan, Xichun Hu, Tao Sun, Wei Li, Qingyuan Zhang, Shude Cui, Ying Cheng, Quchang Ouyang, Xiaojia Wang, Zhendong Chen, (unknown), Kenichi Saito, Setsuo Funasaka, Binghe Xu	68
8	Synthesis and structure–activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), Yoshinobu Yamane, Setsuo Funasaka, Keigo Tanaka, Kazuki Miyazaki, Yoshihiko Kotake, Junichi Kamata, (unknown), (unknown), Yoichi Ozawa, Yoshiharu Mizui, Kiyoshi Okamoto, Daisuke Ito	3
9	Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor 2011 ·International Journal of Molecular Medicine ·Kiyoshi Okamoto, Daisuke Ito, Kazuki Miyazaki, (unknown), Osamu Tohyama, Akira Yokoi, Yoichi Ozawa, Makoto Asano, Takanori Kawamura, Yoshinobu Yamane, (unknown), Setsuo Funasaka, Junichi Kamata, Yoshihiko Kotake, Mika Aoki, (unknown), Yoshiharu Mizui, Isao Tanaka, Kohei Sawada	9
10	E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models 2009 ·Cancer Science ·Takayuki Nakagawa, Osamu Tohyama, Atsumi Yamaguchi, Tomohiro Matsushima, Keiko Takahashi, Setsuo Funasaka, (unknown), Makoto Asada, Hiroshi Obaishi	97
11	Highly Efficient Method for the Synthesis of Carboxamides from Carboxylic Acids and Amines Using Pyridine-3-sulfonyl Chloride (3-PSC) 2008 ·Chemistry Letters ·Setsuo Funasaka, Koji Kato, Teruaki Mukaiyama	3
12	A Versatile, Practical, and Inexpensive Reagent, Pyridine-3-carboxylic Anhydride (3-PCA), for Condensation Reactions 2008 ·Bulletin of the Chemical Society of Japan ·Setsuo Funasaka, Teruaki Mukaiyama	13
13	Highly Efficient Method for the Synthesis of Carboxamides from Carboxylic Acids and Amines Using Benzenesulfonic Anhydride (BSA) 2007 ·Chemistry Letters ·Setsuo Funasaka, Koji Kato, Teruaki Mukaiyama	4
14	Pyridine-3-carboxylic Anhydride (3-PCA): A Versatile, Practical, and Inexpensive Reagent for Condensation Reaction between Carboxylic Acids and Alcohols 2007 ·Chemistry Letters ·Teruaki Mukaiyama, Setsuo Funasaka	18
15	Efficient Method for Dehydration Condensation Using Pyridine-3-carboxylic Anhydride (3-PCA): Synthesis of Carboxamides from Nearly Equimolar Amounts of Carboxylic Acids and Amines 2007 ·Chemistry Letters ·Setsuo Funasaka, Teruaki Mukaiyama	7
16	Catalytic and Stereoselective Glycosylation with Glucosyl Thioformimidates 2003 ·Bulletin of the Chemical Society of Japan ·Hiroyuki Chiba, Setsuo Funasaka, Teruaki Mukaiyama	31
17	Catalytic and Stereoselective Glycosylation with a Novel and Efficient Disarmed Glycosyl Donor: Glycosyl p-Trifluoromethylbenzylthio-p-trifluoromethylphenyl Formimidate 2002 ·Chemistry Letters ·Teruaki Mukaiyama, Hiroyuki Chiba, Setsuo Funasaka	7
18	Catalytic and Chemoselective Glycosylation between “Armed” and “Disarmed” Glycosyl p-Trifluoromethylbenzylthio-p-trifluoromethylphenyl Formimidates 2002 ·Chemistry Letters ·Hiroyuki Chiba, Setsuo Funasaka, (unknown), Teruaki Mukaiyama	15
19	Synthesis of Vicinal Bis(alkylthio) Derivatives by Reductive Coupling of Dithioacetals Derived from Aromatic Aldehydes with Low Valent Titanium Iodide Species 2001 ·Chemistry Letters ·(unknown), Koji Igarashi, Setsuo Funasaka, Teruaki Mukaiyama	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact